CN1139114A - Prepn process of adenosine triphosphate from hypoxanthine nucleotide - Google Patents

Prepn process of adenosine triphosphate from hypoxanthine nucleotide Download PDF

Info

Publication number
CN1139114A
CN1139114A CN 95106298 CN95106298A CN1139114A CN 1139114 A CN1139114 A CN 1139114A CN 95106298 CN95106298 CN 95106298 CN 95106298 A CN95106298 A CN 95106298A CN 1139114 A CN1139114 A CN 1139114A
Authority
CN
China
Prior art keywords
reaction
yeast
triphosaden
reaction system
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 95106298
Other languages
Chinese (zh)
Inventor
陆传宗
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 95106298 priority Critical patent/CN1139114A/en
Publication of CN1139114A publication Critical patent/CN1139114A/en
Pending legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The said prepn process is that in the presence of ammonium ion and magnesium ion, hypoxanthine nucleotide is converted into adenosine monophosphate, which is then converted into adenosine triphosphate via fermentation with yeast. It has low cost and high conversion.

Description

A kind of method for preparing Triphosaden by inosinic acid
The present invention relates to biochemical field, particularly a kind of preparation method of Triphosaden.
Triphosaden (hereinafter to be referred as ATP) is a kind of Nucleotide medicine, and it contains high-energy phosphate bond, is energy converter, reservoir, plays an important role in human energy metabolism.Using it clinically always and do the first aid medication, also is important adjuvant drug.Develop its enteric coated tablet in recent years, be used as the medicine that cures mainly of gastroptosis.ATP also can do the agent that boils together and use in food.
What the preparation method of ATP adopted the earliest is to extract from rabbit flesh, or synthesizes ATP with the photosynthesis of spinach.Production method commonly used at present is to make raw material with adenylic acid (AMP) and adenosine (AR), produces ATP with yeast fermentation method, and this method exists the high problem of cost.
The purpose of this invention is to provide a kind of method of utilizing inosinic acid (IMP) to make the feedstock production Triphosaden.
Method of the present invention makes adenylic acid change into Triphosaden by yeast fermentation for to make inosinic acid change into adenylic acid in the presence of glucose, yeast, ammonium ion and magnesium ion then.
Ammonium ion in the described method especially preferably uses ammonium chloride or ammonium hydroxide as the donor of amino.Described magnesium ion plays katalysis, available magnesium chloride.Wherein the IMP temperature of reaction that changes into AMP is preferably 28~32 ℃, preferred 10~24 hours of reaction times, reaction system parts by weight formula optimization: IMP0.1~0.2 part, NH 4OH (NH 4Cl) 0.02~0.1 part, MgCl 20.05~0.3 part, 0.6~1.5 part of glucose, 3~4 parts in yeast.
The adenylic acid of the inventive method changes in the reaction system of Triphosaden, particularly contain glucose, yeast, potassium primary phosphate and magnesium chloride, also the available hydrogen sodium oxide is transferred PH, as transfer to PH7, preferred 28~32 ℃ of this temperature of reaction, preferred 6~8 hours of reaction times, the parts by weight proportion optimization of described reaction system is: 0.5~1 part of potassium primary phosphate, 0.05~0.1 part in magnesium chloride, 1~2 part of glucose, 4~6 parts in yeast, the amount of AMP is in 0.1~0.2 part of amount that IMP was changed into.
Key of the present invention is the step that IMP changes into AMP.In the prior art, IMP transforms and generates AMP and GMP (guanylic acid), and the transformation efficiency that IMP changes into AMP has only about 50%.And IMP only generates AMP basically in the method for the invention, does not almost have GMP to generate.Make low-cost, high conversion ground become possibility like this, opened up the new of ATP production, feasible way by IMP production ATP.
So the transformation efficiency that present method makes IMP generate AMP has improved nearly one times, greatly reduces the production cost of ATP.In addition, present method reaction conditions is simple, and speed of response is very fast.
Further specify the present invention below by embodiment.
Get IMP0.15 gram, NH 4OH60 μ M, MgCl 20.15 gram, yeast 3.5 grams, mix the back and reacted 15 hours about 30 ℃, add 0.75 gram potassium primary phosphate, 0.08 gram magnesium chloride, 1.5 gram glucose then after aftertreatment, transferring PH with sodium hydroxide is 7, cumulative volume is 10 milliliters in the aqueous solution, and reaction is 7 hours about 30 ℃.
Reaction finishes the logical steam heating (100 ℃) in back 5~10 minutes, and centrifugal (3000~5000 rev/mins) 5~10 minutes get supernatant liquor, and with 3 times of deionized water dilutions, last ion exchange resin column separates.For obtaining being fit to the ATP of injection medicine inspection standard, after separating with anionite-exchange resin (polystyrene-divinylbenzene quaternary amine type, degree of crosslinking 1 * 8, granularity 100~200 orders) post, also need with the diatomite source of reducing phlegm and internal heat.For obtaining being fit to the ATP of tablet medicine inspection standard, after the anion-exchange resin column separation, use cloudy post (or good activated carbon column) to concentrate again, elute and promptly can be used as compressing tablet.
Post treatment method can adopt any suitable method of prior art, can be with reference to " production of ucleotides material and application " data compilation, Science Press, 1971.

Claims (10)

1. the preparation method of a Triphosaden is characterized in that making in the presence of ammonium ion inosinic acid to change into adenylic acid, makes adenylic acid change into Triphosaden by yeast fermentation then.
2. method as claimed in claim 1 is characterized in that also having glucose, yeast, magnesium ion in the reaction system of inosinic acid.
3. as the method for claim 1 or 2, it is characterized in that described ammonium ion is with ammonium chloride or ammonium hydroxide.
4. method as claimed in claim 2 is characterized in that described magnesium ion magnesium chloride.
5. as the method for claim 1 or 2, it is characterized in that temperature of reaction is 28~32 ℃.
6. method as claimed in claim 2 is characterized in that the reaction system parts by weight prescription of inosinic acid is: IMP0.1~0.2 part, NH 4OH (or NH 4Cl) 0.02~0.1 part, MgCl 20.05~0.3 part, 0.6~1.5 part of glucose, 3~4 parts in yeast, temperature of reaction is 28~32 ℃, 10~24 hours reaction times.
7. as the method for claim 1 or 2, it is characterized in that adenylic acid changes in the reaction system of Triphosaden, contains glucose, yeast, potassium primary phosphate and magnesium chloride.
8. method as claimed in claim 7, it is characterized in that the parts by weight proportioning that adenylic acid changes into the reaction system of Triphosaden is 0.5~1 part of a potassium primary phosphate, 0.05~0.1 part in magnesium chloride, 1~2 part of glucose, 4~6 parts in yeast, the amount of AMP is in 0.1~0.2 part of amount that IMP was changed into, and temperature of reaction is 28~32 ℃, and the reaction times is 6~8 hours.
9. method as claimed in claim 7 is characterized in that the reaction system that AMP changes into ATP regulates pH value with sodium hydroxide.
10. as the method for claim 1 or 2, it is characterized in that transforming obtain ATP after, logical steam heating 5~10 minutes, centrifugal (3000~5000 rev/mins) 5~10 minutes get supernatant liquor, after the deionized water dilution, last ion exchange resin column separates.
CN 95106298 1995-06-28 1995-06-28 Prepn process of adenosine triphosphate from hypoxanthine nucleotide Pending CN1139114A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 95106298 CN1139114A (en) 1995-06-28 1995-06-28 Prepn process of adenosine triphosphate from hypoxanthine nucleotide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 95106298 CN1139114A (en) 1995-06-28 1995-06-28 Prepn process of adenosine triphosphate from hypoxanthine nucleotide

Publications (1)

Publication Number Publication Date
CN1139114A true CN1139114A (en) 1997-01-01

Family

ID=5075861

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 95106298 Pending CN1139114A (en) 1995-06-28 1995-06-28 Prepn process of adenosine triphosphate from hypoxanthine nucleotide

Country Status (1)

Country Link
CN (1) CN1139114A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109851650A (en) * 2018-12-19 2019-06-07 新疆阜丰生物科技有限公司 A method of extracting adenosine from fermentation liquid
WO2019109560A1 (en) * 2017-12-05 2019-06-13 中国科学院化学研究所 Method for extracting adenosine triphosphate from adenosine triphosphate solution

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019109560A1 (en) * 2017-12-05 2019-06-13 中国科学院化学研究所 Method for extracting adenosine triphosphate from adenosine triphosphate solution
CN109851650A (en) * 2018-12-19 2019-06-07 新疆阜丰生物科技有限公司 A method of extracting adenosine from fermentation liquid

Similar Documents

Publication Publication Date Title
Engelhardt et al. Myosine and adenosinetriphosphatase
Lohrmann et al. Prebiotic activation processes
CN104109701B (en) Adenosine triphosphate preparation method
US20170130254A1 (en) Nucleotide production process
CN108018252B (en) Preparation method of intermediate 2' -deoxyguanosine
CN1139114A (en) Prepn process of adenosine triphosphate from hypoxanthine nucleotide
Braell et al. A new procedure for the preparation of GDP-[U-14C] mannose
CN111705096A (en) Method for producing beta-nicotinamide mononucleotide by enzyme conversion method
CN103849666B (en) A kind of method of immobilized enzyme catalysis production CITICOLINE SODIUM
WO2018201642A1 (en) Method for use in synthesizing shikimic acid
CN107916282B (en) Method for preparing L-citrulline and L-ornithine by biological method
Friedberg et al. Mechanism of O-alkyl lipid synthesis
Cunningham et al. Soluble RNA polymerase from rat liver nuclei
CN104830930A (en) Nucleoside drug intermediate 2 '-deoxyguanosine production method
CN104946674B (en) A kind of adenosine triphosphate/bisphosphatase and its encoding gene and application
CN114262726A (en) Method for synthesizing citicoline sodium by using cytidine enzymatic method
CN100489111C (en) Process for producing CMP-N-acetylneuraminic acid
CN116064701A (en) Production process of beta-nicotinamide mononucleotide
US3157636A (en) Method for purification of 5'-purine-nucleotides
CN101156936B (en) An administer orally mixed nucleus glycosides as well as its preparing technics
WO2024216536A1 (en) Method for preparing ribonucleoside or derivative thereof, and biological enzyme preparation and application thereof
JPS5985298A (en) Production of 3'-deoxyguanosine
CN101230372B (en) Method for synthesizing uridine diphosphate-N-acetylglucosamine through whole-cell biocatalysis
CN113403356A (en) Preparation method of high-purity ribose-1-phosphate
JPH0573391B2 (en)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication